FDA Opens Way for Diabetic Macular Edema Device

| Jan 1, 2014

The Food and Drug Adminsitration, reversing itself on a decision it made in October, has opened the way for a new treatment for diabetic macular edema to reach the U.S. market.

The treatment, Iluvien, is a tiny insert implanted into the eye via a needle. It carries a drug used to treat DME, a condition that develops in many people with diabetes and can lead to blindness.

Iluvien's developers, Watertown, MA-based pSivida and Alpharetta, GA-based Alimera Sciences, had been told only three months ago by the FDA that the federal agency could not approve the companies' application "in its present form."

Concerned with what it cited as "clinical and statistical deficiencies," as well as problems with Iluvien's manufacturing facility, the FDA said that addressing those concerns might require up to a year of additional product trials and meetings with agency advisors.

The new agency ruling removed those conditions, opening the way for the companies to prepare labeling proposals that they hope to submit to the FDA by late March. That step is a final step before the agency grants marketing approval.

Iluvien is approved for use in Europe, and potential sales of the device are expected to reach $400 million. Statistics for U.S. market revenues have not been estimated.

Click Here To View Or Post Comments

Categories: Diabetic Macular Edema, DME, FDA, Iluvien, pSivida

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Jan 1, 2014

©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.